Health
Full intensity heparin has value in treating hospitalized COVID-19 patients – News-Medical.Net
Results from the RAPID clinical trial suggest heparin may lower the risk of death from moderate COVID-19 infection by 78%. Heparin…
Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers led by Peter Jüni of St. Michael’s Hospital and the University…
Continue Reading
-
General16 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News19 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News21 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
Noosa News24 hours agoNow Open: The Family Behind Merlo Coffee Continues Its Legacy in Bowen Hills with the Arrival of Milano Bakehouse